Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 602-608

  Cua, D J ^a   Hutchins, B ^a   LaFace, D M ^a   Stohlman, S A ^a   Coffman, R L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADENOVIRUS; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; EXPERIMENTAL MODEL; GENE EXPRESSION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION;

EID: 0035159581     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.602     Document Type: Article

References (39)

1. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
2. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
3. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery
4. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis
5. IL-10 fails to abrogate experimental autoimmune encephalomyelitis
6. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats
7. Interleukin-10 prevents experimental allergic encephalomyelitis in rats
8. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice
9. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis
10. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells
11. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice: Th2-mediated suppression of autoimmune disease
12. Development and characterization of recombinant adenovirus encoding human p53 for gene therapy of cancer
13. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation
14. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography
15. T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice
16. Regulation of intracranial pressure in rat, dog, and man
17. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination
18. Transfer of a foreign gene into the brain using adenovirus vectors
19. Adenovirus-mediated gene transfer and expression of human @B-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice
20. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors
21. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system
22. Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor
23. Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease
24. Local gene therapy with CTLA4immunoglobulin fusion protein in experimental allergic encephalomyelitis
25. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-@B1
26. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of routine experimental autoimmune encephalomyelitis
27. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase
28. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination
29. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T Cell function and amelioration of experimental allergic encephalomyelitis
30. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis
31. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
32. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis
33. 4 integrin by CD4 T cells is required for their entry into brain parenchyma
34. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4
35. 7 integrin
36. Interleukin-10
37. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: Comparison with IL-4 and modulation by IFN-γ or IL-10
38. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
39. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells